157 related articles for article (PubMed ID: 15797353)
1. Efficacy and safety of topiramate in infants according to epilepsy syndromes.
Grosso S; Galimberti D; Farnetani MA; Cioni M; Mostardini R; Vivarelli R; Di Bartolo RM; Bernardoni E; Berardi R; Morgese G; Balestri P
Seizure; 2005 Apr; 14(3):183-9. PubMed ID: 15797353
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of topiramate for intractable childhood generalized epilepsy with epileptic spasms: with special reference to electroencephalographic changes.
Endoh F; Kobayashi K; Hayashi Y; Shibata T; Yoshinaga H; Ohtsuka Y
Seizure; 2012 Sep; 21(7):522-8. PubMed ID: 22698380
[TBL] [Abstract][Full Text] [Related]
3. Topiramate: efficacy and tolerability in children according to epilepsy syndromes.
Mikaeloff Y; de Saint-Martin A; Mancini J; Peudenier S; Pedespan JM; Vallée L; Motte J; Bourgeois M; Arzimanoglou A; Dulac O; Chiron C
Epilepsy Res; 2003 Mar; 53(3):225-32. PubMed ID: 12694931
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of rufinamide in children under four years of age with drug-resistant epilepsies.
Grosso S; Coppola G; Dontin SD; Gobbi G; Pruna D; Accorsi P; Verrotti A; Parisi P; Balestri P
Eur J Paediatr Neurol; 2014 Sep; 18(5):641-5. PubMed ID: 24912730
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study.
Grosso S; Franzoni E; Iannetti P; Incorpora G; Cardinali C; Toldo I; Verrotti A; Caterina Moscano F; Lo Faro V; Mazzone L; Zamponi N; Boniver C; Spalice A; Parisi P; Morgese G; Balestri P
J Child Neurol; 2005 Nov; 20(11):893-7. PubMed ID: 16417859
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and side effects of topiramate on refractory epilepsy in infants and young children: a multi-center clinical trial.
Al Ajlouni S; Shorman A; Daoud AS
Seizure; 2005 Oct; 14(7):459-63. PubMed ID: 16087357
[TBL] [Abstract][Full Text] [Related]
7. Topiramate in long-term treatment of epilepsy in the intellectually disabled.
Arvio M; Sillanpää M
J Intellect Disabil Res; 2005 Mar; 49(Pt 3):183-9. PubMed ID: 15713193
[TBL] [Abstract][Full Text] [Related]
8. A prospective study on the treatment of infantile spasms with first-line topiramate followed by low-dose ACTH.
Zhu X; Chen O; Zhang D; Jin R; Li F; Wang Y; Sun R
Epilepsy Res; 2011 Feb; 93(2-3):149-54. PubMed ID: 21205578
[TBL] [Abstract][Full Text] [Related]
9. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group.
Abou-Khalil B
Epilepsia; 2000; 41(S1):72-6. PubMed ID: 10768305
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with open-label topiramate use in infants younger than 2 years of age.
Watemberg N; Goldberg-Stern H; Ben-Zeev B; Berger I; Straussberg R; Kivity S; Kramer U; Brand N; Lerman-Sagie T
J Child Neurol; 2003 Apr; 18(4):258-62. PubMed ID: 12760428
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: a clinical experience.
Mohamed K; Appleton R; Rosenbloom L
Seizure; 2000 Mar; 9(2):137-41. PubMed ID: 10845739
[TBL] [Abstract][Full Text] [Related]
12. Retrospective study of topiramate in a paediatric population with intractable epilepsy showing promising effects in the West syndrome patients.
Thijs J; Verhelst H; Van Coster R
Acta Neurol Belg; 2001 Sep; 101(3):171-6. PubMed ID: 11817266
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy.
Grosso S; Cordelli DM; Franzoni E; Coppola G; Capovilla G; Zamponi N; Verrotti A; Morgese G; Balestri P
Seizure; 2007 Jun; 16(4):345-50. PubMed ID: 17368928
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of topiramate in children younger than 2 years old.
Valencia I; Fons C; Kothare SV; Khurana DS; Yum S; Hardison HH; Legido A
J Child Neurol; 2005 Aug; 20(8):667-9. PubMed ID: 16225812
[TBL] [Abstract][Full Text] [Related]
15. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
Helmstaedter C; Witt JA
Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
[TBL] [Abstract][Full Text] [Related]
16. Topiramate for the treatment of infantile spasms.
Hosain SA; Merchant S; Solomon GE; Chutorian A
J Child Neurol; 2006 Jan; 21(1):17-9. PubMed ID: 16551447
[TBL] [Abstract][Full Text] [Related]
17. Low-dose topiramate is effective in the treatment of infantile spasms.
Hsieh MY; Lin KL; Wang HS; Chou ML; Hung PC; Chang MY
Chang Gung Med J; 2006; 29(3):291-6. PubMed ID: 16924891
[TBL] [Abstract][Full Text] [Related]
18. Topiramate in frontal lobe epilepsy.
Verrotti A; Sofia V; Franzoni E; Coppola G; Manco R; Ciambra GL; Savasta S; Chiarelli F; Iannetti P
Acta Neurol Scand; 2007 Feb; 115(2):132-5. PubMed ID: 17212619
[TBL] [Abstract][Full Text] [Related]
19. Topiramate and metabolic acidosis in infants and toddlers.
Philippi H; Boor R; Reitter B
Epilepsia; 2002 Jul; 43(7):744-7. PubMed ID: 12102678
[TBL] [Abstract][Full Text] [Related]
20. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
